10-Q: Venus Concept Inc. Reports First Quarter 2024 Results Amid Strategic Review

Venus Concept Inc. reported a net loss of $9.8 million for the first quarter of 2024, alongside a strategic review of alternatives to enhance shareholder value.

Summary

• Venus Concept Inc. reported a net loss of $9.8 million for the first quarter of 2024, compared to a net loss of $9.6 million in the same period last year.
• The company's revenue decreased by 14.9% to $17.5 million, primarily due to a strategic shift away from subscription-based sales and the exit of unprofitable international markets.
• Gross profit decreased by 15% to $11.6 million, with a gross margin of 66.6%.
• Operating expenses totaled $19.4 million, a decrease of 11.2% year-over-year.
• The company's cash used in operations was $2.9 million, a 51% improvement compared to the $5.9 million used in the first quarter of 2023.
• As of March 31, 2024, Venus Concept had $5.1 million in cash and cash equivalents.
• The company is undergoing a strategic review to maximize shareholder value, which may include financings, mergers, or asset sales.
• The company has an accumulated deficit of $271.7 million as of March 31, 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are some positive signs like improved cash flow and cost control, the significant revenue decline, net loss, and ongoing strategic review indicate substantial challenges and uncertainty. The company's ability to continue as a going concern is also a concern.

Positives

• Cash used in operations improved significantly, decreasing by 51% year-over-year.
• Operating expenses decreased by 11.2% year-over-year, indicating cost control efforts.
• The company is actively pursuing strategic alternatives to enhance shareholder value.
• The company has $5.1 million in cash and cash equivalents as of March 31, 2024.

Negatives

• Revenue decreased by 14.9% year-over-year, primarily due to a shift away from subscription-based sales and the exit of unprofitable international markets.
• The company reported a net loss of $9.8 million for the first quarter of 2024.
• The company has an accumulated deficit of $271.7 million as of March 31, 2024.

Risks

• The company's ability to continue as a going concern is uncertain due to recurring losses and negative cash flows.
• The company is dependent on the subscription-based model and Venus Prime financing program, which exposes it to customer credit risk.
• The company's operations are subject to global economic and political uncertainties, including inflation and rising interest rates.
• The company's operations in Israel are subject to political, economic, and military risks.
• The company may face supply chain disruptions and inflationary pressures.
• The company may not be able to maintain its listing on the Nasdaq Capital Market.
• The company is subject to foreign exchange risk due to international operations.

Future Outlook

The company expects to continue to face challenges due to global economic conditions, including inflation and rising interest rates. They are focused on improving cash generation and reducing exposure to credit losses. The company is also actively reviewing strategic alternatives to enhance shareholder value.

Management Comments

• The company's management is focused on adapting to the challenges presented by the current macro-economic environment.
• Management is focused on quality of revenue and despite the revenue decline, cash used in operations was $2.6 million lower than the same period in 2023.
• Management believes that the net proceeds from the Madryn Loan and Security Agreement, the Registered Direct Offering, the 2023 Multi-Tranche Private Placement, the 2022 Private Placement, the proceeds from issuance of our common stock to Lincoln Park, the proceeds from the MSLP Loan, our continued availability under the 2022 LPC Purchase Agreement, our strategic cash flow enhancement initiatives, our initiatives to pursue strategic alternatives, together with our existing cash and cash equivalents, will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months.

Industry Context

The medical aesthetics industry is experiencing a period of uncertainty due to global economic conditions. Venus Concept's strategic shift away from subscription-based sales and focus on cash deals reflects a broader trend in the industry to prioritize cash flow and reduce credit risk. The company's strategic review also indicates a potential shift in the competitive landscape.

Comparison to Industry Standards

• The company's revenue decline of 14.9% is worse than some of its competitors in the medical aesthetics industry, which have shown more resilience in the face of economic headwinds.
• The company's gross margin of 66.6% is within the range of industry standards, but its operating expenses remain high compared to some peers.
• The company's cash burn rate is concerning, but the 51% improvement year-over-year is a positive sign.
• The company's strategic review is similar to actions taken by other companies in the industry facing financial challenges.
• The company's reliance on debt financing is higher than some of its competitors, which may pose a risk in the current economic environment.

Related Party Transactions

• The company had distribution agreements with Technicalbiomed Co., Ltd. (TBC) and Aexel Biomed Pte Ltd. (Aexel Biomed), both of which ceased being related parties as of June 2023.

Stakeholder Impact

• Shareholders face uncertainty due to the company's strategic review and financial challenges.
• Employees may be affected by potential restructuring or changes in operations.
• Customers may experience changes in product availability or service offerings.
• Suppliers may be impacted by the company's financial situation and strategic decisions.
• Creditors face increased risk due to the company's debt obligations and financial challenges.

Next Steps

• The company will continue to evaluate strategic alternatives to maximize shareholder value.
• The company will focus on improving cash generation and reducing exposure to credit losses.
• The company will continue to monitor and mitigate supply chain risks.
• The company will work to regain compliance with Nasdaq listing requirements.

Key Dates

Keywords

medical aesthetics, hair restoration, financial results, strategic review, revenue, net loss, operating expenses, cash flow, debt, equity, Venus Concept, subscription model, Venus Prime, Nasdaq